Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: A Study to Determine the Safety, Tolerability and Efficacy NW-3509A in Patients With Chronic Schizophrenia [Phase 2]
This clinical trial update notes the completion of a Phase 2 study evaluating NW-3509A for safety, tolerability, and efficacy in schizophren…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: 3-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals [NA]
This clinical trial update presents 3-year follow-up clinical outcomes after discontinuation of antipsychotic treatment in individuals with …
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in Treatment of First Episode Psychosis: 3-year Follow-up [Phase 4]
Phase 4 study reporting 3-year follow-up results comparing aripiprazole, quetiapine, and ziprasidone for first-episode psychosis.
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in the Treatment of First Episode Nonaffective Psychosis [Phase 4]
Phase 4 trial comparing aripiprazole, quetiapine, and ziprasidone in first-episode nonaffective psychosis has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 1-year Follow-up [Phase 4]
Phase 4 follow-up study evaluating neurocognitive outcomes in the treatment of first-episode non-affective psychosis over 1 year.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Family-Directed Cognitive Adaptation Program for Individuals With Schizophrenia [NA]
A ClinicalTrials.gov entry indicates the Family-Directed Cognitive Adaptation Program for individuals with schizophrenia has completed its s…
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: Receptor Occupancy of ITI-007 Using Positron Emission Tomography (PET) in Patients With Stable Schizophrenia [Phase 2]
A Phase 2 trial update reports on receptor occupancy of ITI-007 (lumateperone) using PET in stable schizophrenia; the study has been complet…
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: Real Life Assessment of Abilify Maintena
A real-life assessment trial of Abilify Maintena (aripiprazole long-acting injectable) for schizophrenia was terminated.
-
CLINICAL_TRIALS trial_result · 2017-03-09Clinical Trial Update: Integration of Illness Management and Recovery Within ACT [NA]
A completed clinical trial update describes integrating Illness Management and Recovery within Assertive Community Treatment for individuals…
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: Computerized Cognitive-Behavioral Therapy for Auditory Hallucinations [NA]
This clinical trial update notes the completion of a study evaluating computerized cognitive-behavioral therapy for auditory hallucinations …
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Effects of RG1068 (Secretin) on Information Processing in Schizophrenia [Phase 2]
Phase 2 clinical trial update evaluating RG1068 (Secretin) for information processing in schizophrenia; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Transcranial Direct Current Stimulation (tDCS) and Hallucinations in Schizophrenia [NA]
A completed clinical trial assessed transcranial direct current stimulation as a treatment for auditory hallucinations in schizophrenia.
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Brexpiprazole in Patients With Schizophrenia [Phase 3]
Phase 3 clinical trial update showing results posting for brexpiprazole in adults with schizophrenia. The study (NCT01810783) has completed …
-
CLINICAL_TRIALS trial_result · 2017-02-17Clinical Trial Update: Cognitive Remediation Therapy in Schizophrenia: Effects on BDNF Levels [NA]
This update summarizes a completed trial evaluating cognitive remediation therapy in schizophrenia and its effect on Brain-Derived Neurotrop…
-
CLINICAL_TRIALS trial_result · 2017-02-16Clinical Trial Update: Arithmetic Training With the Kumon Method for Cognition in Schizophrenia [NA]
This is a completed clinical trial evaluating arithmetic training with the Kumon method to improve cognitive function in schizophrenia. The …
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral Brexpiprazole (OPC- 34712) in Adolescents With Schizophrenia [Phase 1]
Phase 1 study assessing safety, tolerability, and pharmacokinetics of oral brexpiprazole (OPC-34712) in adolescents with schizophrenia has c…
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Bitopertin in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia [Phase 3]
Phase 3 trial evaluating bitopertin for persistent, predominant negative symptoms of schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: Pregnenolone for Cognitive and Negative Symptoms in Schizophrenia [Phase 2]
Phase 2 clinical trial update on pregnenolone for cognitive and negative symptoms in schizophrenia and schizoaffective disorder. Results wer…
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: Conversion to Antipsychotic Monotherapy [NA]
The clinical trial NCT01368458 evaluating conversion to antipsychotic monotherapy in schizophrenia and schizoaffective disorder has been ter…
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: D-serine for the Schizophrenia Prodrome [Phase 2]
Phase 2 trial update showing results for D-serine in the schizophrenia prodrome; the study completed and results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-02-07Clinical Trial Update: Metformin for Weight Loss in Schizophrenia [NA]
A study evaluating metformin for weight loss in people with schizophrenia and obesity was terminated. Results were posted on 2017-02-07.
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Omega-3 Dietary Supplements in Schizophrenia [NA]
The clinical trial evaluating omega-3 dietary supplements for schizophrenia has completed and its results were posted in February 2017.
-
CLINICAL_TRIALS trial_result · 2017-01-31Clinical Trial Update: PK, Safety, and Tolerability Study of RBP-7000 of Different Molecular Weight Polymer in Subjects With Schizophrenia [Phase 1]
Phase 1 trial assessing the pharmacokinetics, safety, and tolerability of RBP-7000 with polymers of different molecular weights in individua…
-
CLINICAL_TRIALS trial_result · 2017-01-27Clinical Trial Update: A Multicenter Study of NAP (AL-108) in Schizophrenia [Phase 2]
Phase 2 multicenter study evaluating NAP (AL-108) in schizophrenia completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-01-27Clinical Trial Update: Effects of Varenicline on Smoking Lapse in Smokers With and Without Schizophrenia [Phase 4]
Phase 4 clinical trial evaluating the effects of varenicline on smoking lapse in smokers with and without schizophrenia. The study status is…